hero section gradient
15 handpicked stocks

Gen-X Core Holdings

These iconic brands shaped the digital revolution and suburban lifestyle we know today. Our analysts have carefully selected these enduring market leaders for their proven track records and strong positions in technology, retail, and automotive sectors.

Author avatar

Han Tan | Market Analyst

Published on June 17

Your Basket's Financial Footprint

Summary and investor takeaways for the provided market capitalisation breakdown.

Key Takeaways for Investors:
  • Large-cap dominance generally implies lower volatility and more stable returns, aligning with broad-market performance rather than speculative swings.
  • Suitable as a core holding for diversification, not as a high-risk, short-term speculative position.
  • Expect steady, long-term appreciation rather than rapid, explosive gains; growth likely to be gradual and coupled with income.
Total Market Cap
  • MSFT: $3.85T

  • AAPL: $3.90T

  • AMZN: $2.37T

  • Other

About This Group of Stocks

1

Our Expert Thinking

This collection focuses on companies that became household names in the 90s and early 2000s. These businesses have demonstrated remarkable resilience through economic cycles while maintaining leadership in their industries, from software giants to retail powerhouses.

2

What You Need to Know

These stocks represent established market leaders with strong brand loyalty and operational excellence. They offer a balance of growth potential and stability, making them suitable as core portfolio holdings for investors looking for companies with proven staying power.

3

Why These Stocks

Each company was selected for its pioneering role in shaping modern technology, retail, or manufacturing. These businesses not only defined their eras but have also shown the ability to evolve and maintain relevance through continued innovation and market adaptation.

Why You'll Want to Watch These Stocks

🏆

Proven Market Leaders

These companies aren't just survivors - they've dominated their industries for decades. Their established market positions and brand loyalty provide stability other stocks can't match.

🔄

Adaptability Champions

From MS-DOS to cloud computing, cassette tapes to streaming - these companies have successfully navigated multiple technology shifts while maintaining relevance and profitability.

🏗️

Infrastructure Spending Boost

With renewed focus on domestic manufacturing and infrastructure, these industrial and technology giants are perfectly positioned to benefit from major government and private sector investments.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Global Infrastructure Partners: UAE Exposure Risks

Global Infrastructure Partners: UAE Exposure Risks

The UAE's strategic push for economic diversification and smart city development is creating significant demand for advanced construction and infrastructure solutions. This basket provides exposure to a selection of US and EU-listed companies that supply essential materials, technology, and engineering services to the region's projects.

UAE Infrastructure Global Suppliers Breakdown

UAE Infrastructure Global Suppliers Breakdown

As the UAE continues its ambitious economic diversification, demand for world-class infrastructure creates opportunities for the companies that build it. This basket offers exposure to US and EU-listed industrial, materials, and technology firms that are integral to developing these large-scale projects.

Antiviral M&A Wave: Biotech Opportunities in 2025

Antiviral M&A Wave: Biotech Opportunities in 2025

Merck's $9.2 billion acquisition of Cidara Therapeutics strengthens its antiviral pipeline as a key patent nears expiry. This major deal signals a growing trend of pharmaceutical giants buying smaller biotechs, creating potential opportunities among companies with promising infectious disease therapies.

Frequently Asked Questions